Skip to main content

Table 1 Patients included in the study

From: Stability of glycoprotein gene sequences of herpes simplex virus type 2 from primary to recurrent human infection, and diversity of the sequences among patients attending an STD clinic

Patient no* Time between primary and recurrent infection Treatment (valaciclovir)
Primary infection Recurrent infection
1 4 months Yes No
2 2 weeks Yes Yes
3 3 weeks Yes No
4 3 months Yes Yes
5 6 weeks Yes Yes
  1. *All patients were women between 19 and 35 years old.